The DOI matches its Crossref record; 167 of the 176 references it cites were found in a registry or an index.
Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications
Open accessAbstract
Nicotinic acetylcholine receptors (nAChRs) in the muscle, autonomic ganglia, and brain are targets for pharmacologically administered nicotine. Several of the subunits that combine to form neuronal nicotinic receptors have been deleted by knockout or mutated by knockin in mice using homologous recombination. We will review the biochemical, pharmacological, anatomical, physiological, and behavioral phenotypes of mice with genetically altered neuronal nAChR subunits. Clinically relevant mutations in nAChR genes will also be discussed. In addition, some of the signal transduction pathways activated through nAChRs will be described in order to delineate the longer-term changes that might result from persistent activation or inactivation of nAChRs. Genetically manipulated mice have greatly increased our understanding of the subunit composition and physiological properties of nAChRs in vivo. In addition, these mice have provided a model system to determine the molecular basis for many of the pharmacological actions of nicotine on neurotransmitter release and behavior. Genetic manipulations in mice have also elucidated the role of nAChR subunits in various disease states, and suggest several avenues for drug development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nicotinic receptors function as non-selective, excitatory cation channels (Changeux et al., 1998; Picciotto et al., 2001) and occur as homomeric or heteromeric assemblies of a large family of α- and β-subunits (α2-α7 and β2-β4; reviewed in (Picciotto et al., 2000)).”
From Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior (2012) · cites this paper as Picciotto et al., 2001
Citations
Cites
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationLinkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Steinlein, O. K., Mulley, J. C., Propping, P., Wallace, R. H., Phillips, H. A., Sutherland, G. R., Scheffer, I. E., & Berkovic, S. F. (1995) · Nature Genetics · doi:10.1038/ng1095-201 · Cited by 1,134
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073
Wada, E., Wada, K., Boulter, J., Deneris, E. S., Heinemann, S., Patrick, J., & Swanson, L. W. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902840212 · Cited by 1,044
Acetylcholine receptor channel imaged in the open state
Unwin, P. N. T. (1995) · Nature · doi:10.1038/373037a0 · Cited by 1,000
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678
Research works printed but not linked: 7
- Booker, 2000, Analysis of nicotinic receptors containing beta3 subunits in the regulation of anxiety using the beta3 null mutant mice, Soc Neurosci Abstr, 26, 1405
- Grady, 2000, Characterization of dopamine release mediated by the nicotinic acetylcholine receptor inhibited by α-conotoxin MII, Soc Neurosci Abstr, 26, 901
- Leonard, 1998, Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative, Am J Med Genet, 81, 308, 10.1002/(SICI)1096-8628(19980710)81:4<308::AID-AJMG6>3.0.CO;2-P · DOI
- Luo, 2000, α3β2β3 Nicotinic acetylcholine receptors, Soc Neurosci Abstr, 26, 22
- Riley, 1997, Further suggestive evidence for involvement of the α7-nicotinic cholinergic receptor gene on chromosome 15q13-q14 in schizophrenia, Am J Hum Genet, 61, A402
- Rollins, 1993, Reduction in auditory gating following intra-cerebroventricular application of α-bungarotoxin binding site ligands and α-7 antisense oligonucleotides, Soc Neurosci Abstr, 19, 837
- Xu, 1997, Gene targeting of the α7 and β2 subunits and the β4, α3, and α5 cluster of neuronal nicotine acetylcholine receptors, Soc Neurosci Abstr, 23, 391
Cited by
Sorted by citations
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404
Self-citationBrain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 569
Jensen, A. A., Frølund, B., Liljefors, T., & Krogsgaard‐Larsen, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040219e · Cited by 549
Structural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422
Diversity of vertebrate nicotinic acetylcholine receptors
Millar, N. S., & Gotti, C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.041 · Cited by 441
Nicotinic receptor‐mediated effects on appetite and food intake
Jo, Y., Talmage, D. A., & Role, L. W. (2002) · Journal of Neurobiology · doi:10.1002/neu.10147 · Cited by 323
Adriaan Bouwknecht, J., Olivier, B., & Paylor, R. E. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.02.002 · Cited by 256
Moroni, M., Zwart, R., Sher, E., Cassels, B. K., & Bermúdez, I. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023044 · Cited by 286
Millan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 296
Heterogeneity and complexity of native brain nicotinic receptors
Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.023 · Cited by 282
Diversity of native nicotinic receptor subtypes in mammalian brain
Zoli, M., Pistillo, F., & Gotti, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.003 · Cited by 277
Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors
Zoli, M., Pucci, S., Vilella, A., & Gotti, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170912110450 · Cited by 219
Satta, R., Maloku, E., Zhubi, A., Pibiri, F., Hajós, M., Costa, E., & Guidotti, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808699105 · Cited by 202
Merging old and new perspectives on nicotinic acetylcholine receptors
Papke, R. L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.029 · Cited by 183
Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors
McKay, B. E., Placzek, A. N., & Dani, J. A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.001 · Cited by 181
Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology
Pohanka, M. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13022219 · Cited by 188
Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease
Lennon, V. A., Ermilov, L. G., Szurszewski, J. H., & Vernino, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17429 · Cited by 178
McGranahan, T. M., Patzlaff, N. E., Grady, S. R., Heinemann, S. F., & Booker, T. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0937-11.2011 · Cited by 165
Central Nicotinic Receptors: Structure, Function, Ligands, and Therapeutic Potential
Romanelli, M., Gratteri, P., Guandalini, L., Martini, E., Bonaccini, C., & Gualtieri, F. (2007) · ChemMedChem · doi:10.1002/cmdc.200600207 · Cited by 171
Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms
Mudó, G., Belluardo, N., & Fuxe, K. (2006) · Journal of neural transmission · doi:10.1007/s00702-006-0561-z · Cited by 125
Carbone, A., Moroni, M., Groot-Kormelink, P., & Bermúdez, I. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00104.x · Cited by 123
Stevens, T. R., Krueger, S. R., Fitzsimonds, R. M., & Picciotto, M. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-31-10093.2003 · Cited by 119
Self-citationNicotinic Receptors in Neurodegeneration
Posadas, I., López‐Hernández, B., & Ceña, V. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030005 · Cited by 116
Lecca, D., Cacciapaglia, F., Valentini, V., Grønli, J., Spiga, S., & Chiara, G. D. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0280-4 · Cited by 113
Zwart, R., Carbone, A. L., Moroni, M., Bermudez, I., Mogg, A. J., Folly, E. A., Broad, L. M., Williams, A. C., Zhang, D., Ding, C., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045104 · Cited by 111
Toyohara, J., & Hashimoto, K. (2010) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501004010037 · Cited by 109
Davis, J. A., Kenney, J. W., & Gould, T. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3242-07.2007 · Cited by 107
Graef, S., Schönknecht, P., Sabri, O., & Hegerl, U. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2153-8 · Cited by 107
Wehner, J. M., Keller, J. J., Keller, A. B., Picciotto, M. R., Paylor, R. E., Booker, T. K., Beaudet, A. L., Heinemann, S., & Balogh, S. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.016 · Cited by 105
Self-citationLinks Between Depression and Substance Abuse in Adolescents
Rao, U. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.07.002 · Cited by 106
Hashimoto, K., Ishima, T., Fujita, Y., Matsuo, M., Kobashi, T., Takahagi, M., Tsukada, H., & Iyo, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.034 · Cited by 102
Alterations of cortical pyramidal neurons in mice lacking high-affinity nicotinic receptors
Ballesteros-Yáñez, I., Benavides-Piccione, R., Bourgeois, J.-P., Changeux, J.-P., & DeFelipe, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006269107 · Cited by 96
Rowbotham, M. C., Duan, R. W., Thomas, J. W., Nothaft, W., & Bačkonja, M.-M. (2009) · Pain · doi:10.1016/j.pain.2009.06.013 · Cited by 91
Lang, P. M., Burgstahler, R., Sippel, W., Irnich, D., Schlotter‐Weigel, B., & Grafe, P. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00512.2003 · Cited by 92
The Role of Palmitoylation in Functional Expression of Nicotinic α7 Receptors
Drisdel, R. C., Manzana, E., & Green, W. N. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3315-04.2004 · Cited by 90
Nicotinic acetylcholine receptors in neurological and psychiatric diseases
Terry, A. V., Jones, K., & Bertrand, D. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106764 · Cited by 90
Regulation of neuronal nicotinic receptor traffic and expression
Gaimarri, A., Moretti, M., Riganti, L., Zanardi, A., Clementi, F., & Gotti, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.005 · Cited by 89
Sano, K., Isobe, T., Yang, J., Win‐Shwe, T., Yoshikane, M., Nakayama, S. F., Kawashima, T., Suzuki, G., Hashimoto, S., Nohara, K., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00228 · Cited by 88
Wang, N., Orr‐Urtreger, A., & Korczyn, A. D. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00106-5 · Cited by 88
Neuronal and astrocyte expression of nicotinic receptor subunit β4 in the adult mouse brain
Gahring, L. C., Persiyanov, K., & Rogers, S. W. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10942 · Cited by 86
Behavioral Mechanisms Underlying Nicotine Reinforcement
Rupprecht, L. E., Smith, T. T., Schassburger, R. L., Buffalari, D. M., Sved, A. F., & Donny, E. C. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_2 · Cited by 91
Tietje, K. R., Anderson, D. J., Bitner, R., Blomme, E., Brackemeyer, P. J., Briggs, C., Browman, K. E., Bury, D., Curzon, P., Drescher, K., et al. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2008.00037.x · Cited by 91
Hirano, T., Yanai, S., Omotehara, T., HASHIMOTO, R., Umemura, Y., KUBOTA, N., Minami, K., Nagahara, D., Matsuo, E., Aihara, Y., et al. (2015) · Journal of Veterinary Medical Science · doi:10.1292/jvms.15-0188 · Cited by 84
Gahring, L. C., Persiyanov, K., Dunn, D. M., Weiss, R. B., Meyer, E. L., & Rogers, S. W. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10943 · Cited by 84
Ishii, K., Wong, J. K., & Sumikawa, K. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20762 · Cited by 81
Moroni, M., Vijayan, R., Carbone, A. L., Zwart, R., Biggin, P. C., & Bermúdez, I. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1228-08.2008 · Cited by 81
Davis, J. A., & Gould, T. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0047-y · Cited by 78
Gozzi, A., Schwarz, A. J., Reese, T., Bertani, S., Crestan, V., & Bifone, A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300955 · Cited by 77
Davis, J. A., & Gould, T. J. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0624-8 · Cited by 72
Mineur, Y. S., Mose, T. N., Blakeman, S., & Picciotto, M. R. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13769 · Cited by 71
Self-citationÖz, M., Zhang, L., Ravindran, A., Morales, M., & Lupica, C. R. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067751 · Cited by 70
Öz, M., Ravindran, A., Dı́az-Ruiz, O., Zhang, L., & Morales, M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049981 · Cited by 69
Neuronal nicotinic receptors: insights gained from gene knockout an knocking mutant mice
Drago, J., McColl, C. D., Horne, M. K., Finkelstein, D. I., & Ross, S. A. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2259-9 · Cited by 69
Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective
Quednow, B. B., Brzózka, M. M., & Rossner, M. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1553-4 · Cited by 65
Kenney, J. W., Raybuck, J. D., & Gould, T. J. (2012) · Hippocampus · doi:10.1002/hipo.22003 · Cited by 70
Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus
Welsby, P. J., Rowan, M. J., & Anwyl, R. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06562.x · Cited by 64
Hernandez, C. M., Høifødt, H., & Terry, A. V. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0325 · Cited by 62
New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine
Grizzell, J. A., & Echeverrı́a, V. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1359-2 · Cited by 62
Curzon, P., Anderson, D. J., Nikkel, A., Fox, G., Gopalakrishnan, M., Decker, M. W., & Bitner, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.061 · Cited by 62
Spiller, K., Xi, Z.-X., Li, X., Ashby, C. R., Callahan, P. M., Tehim, A., & Gardner, E. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.04.006 · Cited by 58
Papke, R. L., Ono, F., Stokes, C. A., Urban, J. M., & Boyd, R. T. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.022 · Cited by 58
Keller, J. J., Keller, A. B., Bowers, B. J., & Wehner, J. M. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.004 · Cited by 57
Redrobe, J. P., Nielsen, E. Ø., Christensen, J. K., Peters, D., Timmermann, D. B., & Olsen, G. M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.09.035 · Cited by 57
Giribaldi, J., & Dutertre, S. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.063 · Cited by 57
Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors
Barua, S., Kim, J. Y., Kim, J. Y., Kim, J. H., & Lee, J. E. (2019) · Neurochemical Research · doi:10.1007/s11064-018-02712-1 · Cited by 58
Quednow, B. B., Brinkmeyer, J., Mobascher, A., Nothnagel, M., Musso, F., Gründer, G., Savary, N., Petrovsky, N., Frommann, I., Lennertz, L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118051109 · Cited by 56
Campanucci, V. A., Krishnaswamy, A., & Cooper, E. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5130-07.2008 · Cited by 55
Potential therapeutic uses of mecamylamine and its stereoisomers
Nickell, J. R., Grinevich, V. P., Siripurapu, K. B., Smith, A. M., & Dwoskin, L. P. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.04.005 · Cited by 55
Prefrontal neuromodulation by nicotinic receptors for cognitive processes
Coura, R., & Granon, S. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2596-6 · Cited by 57
Engel, J. A., & Jerlhag, E. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63425-2.00009-x · Cited by 53
Acetamiprid Accumulates in Different Amounts in Murine Brain Regions
Terayama, H., Endo, H., Tsukamoto, H., Matsumoto, K., Umezu, M., Kanazawa, T., Ito, M., Sato, T., Naito, M., Kawakami, S., et al. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13100937 · Cited by 50
Lykhmus, O., Koval, L., Voytenko, L. P., Uspenska, K., Комісаренко, С. В., Deryabina, О. G., Shuvalova, N. S., Кордюм, В. А., Ustymenko, A., Kyryk, V. M., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00355 · Cited by 49
Childhood myopia and parental smoking
Saw, S. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.033175 · Cited by 48
Volgin, D. V., Rukhadze, I., & Kubin, L. K. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90670.2008 · Cited by 47
Transdisciplinary tobacco use research
Abrams, D. L., Leslie, F. M., Mermelstein, R. J., Kobus, K., & Clayton, R. (2003) · Nicotine & Tobacco Research · doi:10.1080/14622200310001625519 · Cited by 47
Chen, Y., Sharples, T. J. W., Phillips, K. G., Benedetti, G., Broad, L. M., Zwart, R., & Sher, E. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00189-8 · Cited by 45
Structure of neuronal nicotinic receptors.
Fasoli, F., & Gotti, C. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_1 · Cited by 41
Viveros, M., Marco, E. M., Llorente, R., & Lamota, L. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d28fb4 · Cited by 44
Exley, R., Moroni, M., Sasdelli, F., Houlihan, L. M., Lukas, R., Sher, E., Zwart, R., & Bermúdez, I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03915.x · Cited by 42
Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice
Weiss, S., Tzavara, E. T., Davis, R. J., Nomikos, G. G., McIntosh, J. M., Giros, B., & Martres, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.002 · Cited by 44
Sabec, M. H., Wonnacott, S., Warburton, E. C., & Bashir, Z. I. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.016 · Cited by 42
Tatsumi, R., Fujio, M., Takanashi, S.-I., Numata, A., Katayama, J., Satoh, H., Shiigi, Y., Maeda, J.-I., Kuriyama, M., Horikawa, T., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060249c · Cited by 42
Brunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 43
Self-citationStoker, A. K., Olivier, B., & Markou, A. (2012) · Behavior Genetics · doi:10.1007/s10519-011-9511-0 · Cited by 40
Anderson, S. M., & Brunzell, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048665 · Cited by 41
Self-citationPettersson, A., Nilsson, L. H., Nylund, G., Khorram‐Manesh, A., Nordgren, S., & Delbro, D. S. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.002 · Cited by 40
Shao, X. M., Tan, W., Xiu, J., Puskar, N. L., Fonck, C., Lester, H. A., & Feldman, J. L. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3666-07.2008 · Cited by 39
5-I A-85380 and TC-2559 differentially activate heterologously expressed α4β2 nicotinic receptors
Zwart, R., Broad, L. M., Xi, Q., Lee, M. W., Moroni, M., Bermúdez, I., & Sher, E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.077 · Cited by 38
Öz, M., Spivak, C. E., & Lupica, C. R. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.02.016 · Cited by 37
Kim, S. Y., Kang, K., Lee, J.-C., & Heo, J. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2172-x · Cited by 37
Scholze, P., Orr‐Urtreger, A., Changeux, J., McIntosh, J. M., & Huck, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707236 · Cited by 31
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 33
Pollock, V. V., Pastoor, T., Katnik, C., Cuevas, J., & Wecker, L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.032 · Cited by 31
Zwart, R., Strotton, M., Ching, J., Astles, P., & Sher, E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.031 · Cited by 30
Sugano, T., Yanagita, T., Yokoo, H., Satoh, S., Kobayashi, H., & Wada, A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03846.x · Cited by 32
Yin, Y., Wang, Y., Gao, D., Ye, J., Wang, X., Fang, L., Wu, D., Pi, G., Lu, C., Zhou, X., et al. (2016) · Scientific Reports · doi:10.1038/srep27283 · Cited by 30
α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins
Dawe, G. B., Yu, H. Y., Gu, S., Blackler, A. N., Matta, J. A., Siuda, E. R., Rex, E., & Bredt, D. S. (2019) · Nature Communications · doi:10.1038/s41467-019-10723-x · Cited by 30
Metadata
- Authors
- Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L.
- Affiliations
- Yale University (US)
- Corresponding author
- Picciotto, Marina R
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 92
- Issue
- 2-3
- Pages
- 89-108
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2053266420
- Cited by
- 221
- References
- 176
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 11 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 6 · 2019: 6 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 14 · 2013: 2 · 2012: 17
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- Locations
- Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (DA 10455, DA84733, DA 00436)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- neuronal nicotinic acetylcholine receptors, nicotine pharmacology, signal transduction, neurotransmitter release, behavioral phenotypes, physiological phenotypes, drug development
- MeSH terms
- Animals, Anxiety, Electrophysiology, Learning, Memory, Neurons, Nicotine, Phenotype, Receptors, Nicotinic, Signal Transduction, Point Mutation, Mice, Knockout, Nicotinic Agonists, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review